{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T22:27:47Z","timestamp":1791412067762,"version":"4.3.3"},"reference-count":46,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,11]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>Systemic sclerosis (SSc) subset classification criteria are a cornerstone of SSc research. Given changes in our understanding of the disease and limitations of the current criteria in the conduct of trials, the developments of new SSc subset criteria are underway.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>This article summarizes previous iterations of SSc subset criteria, highlights current thinking about the construct underlying SSc subsets in the modern era and provides an overview of the development of new SSc subset criteria.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>Using a combination of data-driven and expert-based innovative methodologies, a large international collaborative effort is developing new SSc subset criteria. It is anticipated that this new system of classification will shift the paradigm of how we study novel therapies in SSc.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/bor.0000000000000443","type":"journal-article","created":{"date-parts":[[2017,9,20]],"date-time":"2017-09-20T23:53:43Z","timestamp":1505951623000},"page":"568-573","source":"Crossref","is-referenced-by-count":12,"title":["Progress in the clinical classification of systemic sclerosis"],"prefix":"10.1097","volume":"29","author":[{"given":"Sindhu R.","family":"Johnson","sequence":"first","affiliation":[{"name":"Toronto Scleroderma Program, Department of Medicine, Toronto Western Hospital, Toronto, Ontario, Canada"},{"name":"Mount Sinai Hospital, Toronto, Canada"},{"name":"Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230829","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1002\/art.23018","article-title":"Classification criteria in rheumatic diseases: a review of methodologic properties","volume":"57","author":"Johnson","year":"2007","journal-title":"Arthritis Rheum"},{"key":"R2-20230829","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s11926-015-0506-3","article-title":"New ACR EULAR guidelines for systemic sclerosis classification","volume":"17","author":"Johnson","year":"2015","journal-title":"Curr Rheumatol Rep"},{"key":"R3-20230829","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","article-title":"2013 Classification criteria for systemic sclerosis: an American College of Rheumatology\/European League Against Rheumatism Collaborative Initiative","volume":"72","author":"van den Hoogen","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"R4-20230829","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/acr.20679","article-title":"Items for revised classification criteria in systemic sclerosis: results of a consensus exercise with the EULAR\/ACR working group for classification criteria in systemic sclerosis","author":"Fransen","year":"2012","journal-title":"Arthritis Care Res"},{"key":"R5-20230829","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1002\/art.38098","article-title":"2013 Classification criteria for systemic sclerosis: an American College of Rheumatology\/European League against Rheumatism Collaborative Initiative","volume":"65","author":"van den Hoogen","year":"2013","journal-title":"Arthritis Rheum"},{"key":"R6-20230829","doi-asserted-by":"crossref","first-page":"177","DOI":"10.5301\/jsrd.5000198","article-title":"Systemic sclerosis trial design moving forward","volume":"1","author":"Johnson","year":"2016","journal-title":"J Scleroderma Relat Disord"},{"key":"R7-20230829","doi-asserted-by":"crossref","first-page":"e0166629","DOI":"10.1371\/journal.pone.0166629","article-title":"The 2013 American College of Rheumatology\/European League Against Rheumatism Classification Criteria for Systemic Sclerosis could classify systemic sclerosis patients at earlier stage: data from a Chinese EUSTAR center","volume":"11","author":"Xu","year":"2016","journal-title":"PLoS One"},{"key":"R8-20230829","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.semarthrit.2016.05.007","article-title":"Validation of the 2013 American College of Rheumatology\/European League Against Rheumatism classification criteria for systemic sclerosis in patients from a capillaroscopy clinic","volume":"46","author":"Melchor","year":"2016","journal-title":"Semin Arthritis Rheum"},{"key":"R9-20230829","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1093\/rheumatology\/keu530","article-title":"Performance of the new ACR\/EULAR classification criteria for systemic sclerosis in clinical practice","volume":"54","author":"Jordan","year":"2015","journal-title":"Rheumatology (Oxford)"},{"key":"R10-20230829","first-page":"1855","article-title":"Classification criteria for systemic sclerosis subsets","volume":"34","author":"Johnson","year":"2007","journal-title":"J Rheumatol"},{"key":"R11-20230829","first-page":"202","article-title":"Scleroderma (systemic sclerosis): classification, subsets and pathogenesis","volume":"15","author":"LeRoy","year":"1988","journal-title":"J Rheumatol"},{"key":"R12-20230829","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.rdc.2015.04.003","article-title":"New classification criteria for systemic sclerosis (scleroderma)","volume":"41","author":"Pope","year":"2015","journal-title":"Rheum Dis Clin North Am"},{"key":"R13-20230829","doi-asserted-by":"crossref","first-page":"241","DOI":"10.5301\/jsrd.5000216","article-title":"Limited cutaneous systemic sclerosis: the unfairly neglected subset","volume":"1","author":"Allanore","year":"2016","journal-title":"J Scleroderma Relat Disord"},{"key":"R14-20230829","first-page":"200","article-title":"Connective tissue diseases: systemic sclerosis: beyond limited and diffuse subsets? Nature reviews","volume":"10","author":"Varga","year":"2014","journal-title":"Rheumatology"},{"key":"R15-20230829","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/art.22003","article-title":"Development of classification and response criteria for rheumatic diseases","volume":"55","author":"Singh","year":"2006","journal-title":"Arthritis Rheum"},{"key":"R16-20230829","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0950-3579(05)80189-X","article-title":"Methodological and statistical approaches to criteria development in rheumatic diseases","volume":"9","author":"Felson","year":"1995","journal-title":"Baillieres Clin Rheumatol"},{"key":"R17-20230829","first-page":"337","article-title":"The pathophysiology of progressive systemic sclerosis (generalized scleroderma) with special reference to changes in the fiscera","volume":"4","author":"Goetz","year":"1945","journal-title":"Cape Town Post Graduate Med Assoc"},{"key":"R18-20230829","doi-asserted-by":"crossref","first-page":"198","DOI":"10.7326\/0003-4819-57-2-198","article-title":"Diffuse systemic scleroderma. A comparison with acrosclerosis","volume":"57","author":"Tuffanelli","year":"1962","journal-title":"Ann Intern Med"},{"key":"R19-20230829","first-page":"361","article-title":"Multiple telengiectasia, Raynaud's phenomenon, sclerodactyly, and subcutaneous calcinosis: a syndrome mimicking hereditary hemorrhagic telengiectasia","volume":"114","author":"Winterbauer","year":"1964","journal-title":"Bull Johns Hopkins Hosp"},{"key":"R20-20230829","doi-asserted-by":"crossref","first-page":"992","DOI":"10.5694\/j.1326-5377.1969.tb49844.x","article-title":"Scleroderma. 1. Clinical features, course of illness and response to treatment in 61 cases","volume":"1","author":"Barnett","year":"1969","journal-title":"Med J Aust"},{"key":"R21-20230829","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0307-742X(21)00050-3","article-title":"Classification and nomenclature of progressive systemic sclerosis","volume":"5","author":"Rodnan","year":"1979","journal-title":"Clin Rheumatic Dis"},{"key":"R22-20230829","first-page":"911","article-title":"Different antibody patterns and different prognoses in patients with scleroderma with various extent of skin sclerosis","volume":"13","author":"Giordano","year":"1986","journal-title":"J Rheumatol"},{"key":"R23-20230829","first-page":"253","article-title":"Classification of progressive systemic scleroderma","volume":"38","author":"Holzmann","year":"1987","journal-title":"Hautarzt"},{"key":"R24-20230829","first-page":"894","article-title":"Classification of systemic sclerosis (scleroderma): relationship of cutaneous subgroups in early disease to outcome and serologic reactivity","volume":"15","author":"Masi","year":"1988","journal-title":"J Rheumatol"},{"key":"R25-20230829","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1097\/00005792-200203000-00005","article-title":"Predicting mortality in systemic sclerosis: analysis of a cohort of 309 French Canadian patients with emphasis on features at diagnosis as predictive factors for survival","volume":"81","author":"Scussel-Lonzetti","year":"2002","journal-title":"Medicine (Baltimore)"},{"key":"R26-20230829","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/00005792-200203000-00004","article-title":"Systemic sclerosis: demographic, clinical, and serologic features and survival in 1,012 Italian patients","volume":"81","author":"Ferri","year":"2002","journal-title":"Medicine (Baltimore)"},{"key":"R27-20230829","first-page":"S5","article-title":"A working classification of scleroderma spectrum disorders: a proposal and the results of testing on a sample of patients","volume":"22","author":"Maricq","year":"2004","journal-title":"Clin Exp Rheumatol"},{"key":"R28-20230829","first-page":"337","article-title":"The pathophysiology of progressive systemic sclerosis (generalised scleroderma) with special reference to changes in the viscere","volume":"4","author":"Goetz","year":"1945","journal-title":"Clin Proc"},{"key":"R29-20230829","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1136\/pgmj.64.748.121","article-title":"The diagnosis and classification of scleroderma (systemic sclerosis)","volume":"64","author":"Barnett","year":"1988","journal-title":"Postgrad Med J"},{"key":"R30-20230829","first-page":"153","article-title":"Antibody pattern and other criteria for diagnosis and classification of PSS","volume":"15","author":"Burgos-Vargas","year":"1988","journal-title":"J Rheumatol"},{"key":"R31-20230829","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1136\/ard.50.4.267","article-title":"Scleroderma and survival","volume":"50","author":"Silman","year":"1991","journal-title":"Ann Rheum Dis"},{"key":"R32-20230829","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/rheumatology\/23.4.267","article-title":"HLA antigens, autoantibodies and clinical subsets in scleroderma","volume":"23","author":"Black","year":"1984","journal-title":"Br J Rheumatol"},{"key":"R33-20230829","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1136\/ard.2006.062901","article-title":"Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research (EUSTAR) group data base","volume":"66","author":"Walker","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"R34-20230829","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1136\/ard.57.11.682","article-title":"Mortality and causes of death in a Swedish series of systemic sclerosis patients","volume":"57","author":"Hesselstrand","year":"1998","journal-title":"Ann Rheum Dis"},{"key":"R35-20230829","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0954-6111(96)90291-7","article-title":"Lung involvement in systemic sclerosis (scleroderma): relation to classification based on extent of skin involvement or autoantibody status","volume":"90","author":"Kane","year":"1996","journal-title":"Respir Med"},{"key":"R36-20230829","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1093\/rheumatology\/keh671","article-title":"Classification of systemic sclerosis. Visions and reality","volume":"44","author":"Wollheim","year":"2005","journal-title":"Rheumatology (Oxford)"},{"key":"R37-20230829","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1136\/annrheumdis-2012-202295","article-title":"Very early versus early disease: the evolving definition of the \u2018many faces\u2019 of systemic sclerosis","volume":"72","author":"Matucci-Cerinic","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"R38-20230829","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1136\/annrheumdis-2013-203716","article-title":"Preliminary analysis of the Very Early Diagnosis of Systemic Sclerosis (VEDOSS) EUSTAR multicentre study: evidence for puffy fingers as a pivotal sign for suspicion of systemic sclerosis","volume":"73","author":"Minier","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"R39-20230829","first-page":"104","article-title":"Disease subsets, antinuclear antibody profile, and clinical features in 127 French and 247 US adult patients with systemic sclerosis","volume":"34","author":"Meyer","year":"2007","journal-title":"J Rheumatol"},{"key":"R40-20230829","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1002\/art.24586","article-title":"Anti-U11\/U12 RNP antibodies in systemic sclerosis: a new serologic marker associated with pulmonary fibrosis","volume":"61","author":"Fertig","year":"2009","journal-title":"Arthritis Rheum"},{"key":"R41-20230829","doi-asserted-by":"crossref","first-page":"e1002178","DOI":"10.1371\/journal.pgen.1002178","article-title":"Identification of novel genetic markers associated with clinical phenotypes of systemic sclerosis through a genome-wide association strategy","volume":"7","author":"Gorlova","year":"2011","journal-title":"PLoS Genet"},{"key":"R42-20230829","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1056\/NEJMoa1114576","article-title":"Proteome-wide analysis and CXCL4 as a biomarker in systemic sclerosis","volume":"370","author":"van Bon","year":"2014","journal-title":"N Engl J Med"},{"key":"R43-20230829","article-title":"There is a need for new systemic sclerosis subset classification criteria: a content analytic approach","author":"Johnson","year":"2017","journal-title":"Scand J Rheumatol"},{"key":"R44-20230829","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nmeth.2810","article-title":"Similarity network fusion for aggregating data types on a genomic scale","volume":"11","author":"Wang","year":"2014","journal-title":"Nat Methods"},{"key":"R45-20230829","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.semarthrit.2010.12.001","article-title":"Methods of formal consensus in classification\/diagnostic criteria and guideline development","volume":"41","author":"Nair","year":"2011","journal-title":"Semin Arthritis Rheum"},{"key":"R46-20230829","doi-asserted-by":"crossref","first-page":"277","DOI":"10.5301\/jsrd.5000213","article-title":"Controversies: molecular vs. clinical systemic sclerosis classification","volume":"1","author":"Johnson","year":"2016","journal-title":"J Scleroderma Relat Disord"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00002281-201711000-00004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T06:36:56Z","timestamp":1693291016000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002281-201711000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":46,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/bor.0000000000000443","relation":{},"ISSN":["1040-8711","1531-6963"],"issn-type":[{"value":"1040-8711","type":"print"},{"value":"1531-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11]]}}}